Directory
>
Madan Jagasia
Madan Jagasia
Chief Executive Officer | Obsidian Therapeutics
United States
Madan Jagasia
Summary
Madan Jagasia is a seasoned biotechnology executive with extensive expertise in oncology and clinical research. He currently serves as the CEO of Obsidian Therapeutics, where he leads innovative cell and gene therapy initiatives. With a strong academic background, including dual master's degrees from Vanderbilt University, he has a solid foundation in healthcare management and clinical investigation. Madan's previous roles include Executive Vice President of Medical Affairs at Iovance Biotherapeutics, where he played a key role in national medical affairs and strategic collaborations. His leadership experience spans over two decades in both clinical and research settings, particularly within prestigious institutions like Vanderbilt University Medical Center. Notably, he has contributed significantly to the development of tumor-infiltrating lymphocyte treatments for cancer. He is recognized internationally for his contributions to cancer therapy and is dedicated to advancing healthcare through innovative research and management practices.
Madan Jagasia
Work Experience
Chief Executive Officer at
Obsidian Therapeutics
January 2023 - Present
Executive Vice President, Medical Affairs at
Iovance Biotherapeutics, Inc.
July 2022 - January 2023
Senior Vice President, Medical Affairs at
Iovance Biotherapeutics, Inc.
August 2020 - July 2022
Deputy Director of Clinical Affairs, Vanderbilt-Ingram Cancer Center at
Vanderbilt University Medical Center
January 2019 - July 2020
Chief Medical Officer, Vanderbilt Ingram Cancer Center at
Vanderbilt University Medical Center
July 2018 - July 2020
Professor of Medicine at
Vanderbilt University Medical Center
July 2010 - July 2018
Medical Director, Division of Hematology-Oncology at
Vanderbilt University Medical Center
September 2016 - June 2018
Section Chief of Hematology and Stem Cell Transplant at
Vanderbilt University Medical Center
October 2010 - June 2018
Associate Professor Of Medicine at
Vanderbilt University Medical Center
January 2008 - June 2010
Assistant Professor Of Medicine at
Vanderbilt University Medical Center
January 2001 - January 2008
Madan Jagasia
Education
Vanderbilt University - Owen Graduate School of Management, Masters Of Management In Healthcare Management
January 2016 - January 2017
Vanderbilt University, Masters Of Science In Clinical Investigation
January 2004 - January 2006
GS Medical College & KEM Hospital, Mumbai, Bachelor Of Medicine, Bachelor Of Surgery - Mbbs
January 1986 - January 1990
Frequently Asked Questions about Madan Jagasia
What is Madan Jagasia email address?
Madan Jagasia's primary email address is *************@vanderbilt.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Madan Jagasia work for?
Madan Jagasia is a Chief Executive Officer at Obsidian Therapeutics, a company specializing in Commercial physical research.
Where Madan Jagasia graduated from?
Madan Jagasia holds a degree in Health/Health Care Administration/Management from Vanderbilt University - Owen Graduate School of Management.
How can I directly contact Madan Jagasia?
To contact Madan Jagasia directly, you can use the email address *************@vanderbilt.edu. Complete contact information is available upon registration with Muraena.
Is Madan Jagasia an immigrant?
Yes, Madan Jagasia is an immigrant and currently based in United States
Who is Madan Jagasia?
Madan Jagasia is a seasoned biotechnology executive with extensive expertise in oncology and clinical research. He currently serves as the CEO of Obsidian Therapeutics, where he leads innovative cell and gene therapy initiatives. With a strong academic background, including dual master's degrees from Vanderbilt University, he has a solid foundation in healthcare management and clinical investigation. Madan's previous roles include Executive Vice President of Medical Affairs at Iovance Biotherapeutics, where he played a key role in national medical affairs and strategic collaborations. His leadership experience spans over two decades in both clinical and research settings, particularly within prestigious institutions like Vanderbilt University Medical Center. Notably, he has contributed significantly to the development of tumor-infiltrating lymphocyte treatments for cancer. He is recognized internationally for his contributions to cancer therapy and is dedicated to advancing healthcare through innovative research and management practices.
Madan`s contact details
*************@vanderbilt.edu
*************@vanderbilthealth.com
********@obsidiantx.com
Colleagues
Vice President Regulatory Affairs
Vice President, Analytical Development
Vice President, Head of Cell Therapy
Vice President of IT and Facilities
Vice President Clinical Sciences
Vice President - Process Development and Manufacturing
Vice President, Head of Intellectual Property
Chief People Officer
Vice President, Clinical Operations & Translational Early Clinical Development